These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6285942)

  • 1. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of immunosuppression in lung cancer by normal sera.
    Hadjipetrou-Kourounakis L; Manikou H; Tsougranis A
    J Clin Lab Immunol; 1985 Mar; 16(3):149-53. PubMed ID: 4032453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].
    Dominioni L; Dionigi R; Cremaschi P; Nascimbene C; Cividini F; Mori A; Pecis C; Asti S; Moncalvo F; Campani M
    Chir Ital; 1981 Feb; 33(1):47-59. PubMed ID: 7261218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
    Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological status in small cell and squamous cell lung cancer].
    Janicka G; Przylipiak M; Chyczewska E; Kowal E
    Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
    Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
    Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of cell-mediated effector mechanisms in lung cancer.
    Feo Figarella E; Morillo F; Blanca I; Bianco NE
    J Natl Cancer Inst; 1984 Jul; 73(1):1-6. PubMed ID: 6330420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer.
    Masuno T; Ikeda T; Yokota S; Komuta K; Ogura T; Kishimoto S
    Cancer Res; 1986 Aug; 46(8):4195-9. PubMed ID: 3015385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of regional lymph nodes in patients with lung cancer.
    Ogawa J; Inoue H; Koide S; Kawada S; Shohtsu A
    Tokai J Exp Clin Med; 1981 Jul; 6(3):259-66. PubMed ID: 6975508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cellular immunity in pulmonary sarcoidosis and primary lung cancer].
    Li JP
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):100-2, 128. PubMed ID: 1327551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune status of patients with bronchial cancer].
    Aulenbacher P; Manke HG; Drings P
    Klin Wochenschr; 1987 May; 65(10):445-52. PubMed ID: 3037180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte mitogen stimulation studies for patients with lung cancer: evaluation of prognostic significance of preirradiation therapy studies.
    Dalbow MH; Concannon JP; Eng CP; Weil CS; Conway J; Narayanan Nambisan PT
    J Lab Clin Med; 1977 Aug; 90(2):295-302. PubMed ID: 886214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
    Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
    Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulins and complement components levels in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
    Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating immunocomplexes in lung neoplasms].
    Pesek M; Sefrna F; Simecek C; Racek J
    Vnitr Lek; 1982 Jun; 28(6):571-6. PubMed ID: 6287725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.